Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 18591252)

1.

Epigenetic mechanisms of induced pluripotency.

Gładych M, Andrzejewska A, Oleksiewicz U, Estécio MR.

Contemp Oncol (Pozn). 2015;19(1A):A30-8. doi: 10.5114/wo.2014.47135. Review.

2.

Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy.

Rosenberg A, Fan H, Chiu YG, Bolce R, Tabechian D, Barrett R, Moorehead S, Baribaud F, Liu H, Peffer N, Shealy D, Schwarz EM, Ritchlin CT.

PLoS One. 2014 Oct 21;9(10):e110657. doi: 10.1371/journal.pone.0110657. eCollection 2014.

3.

The roles of Jumonji-type oxygenases in human disease.

Johansson C, Tumber A, Che K, Cain P, Nowak R, Gileadi C, Oppermann U.

Epigenomics. 2014 Feb;6(1):89-120. doi: 10.2217/epi.13.79. Review.

4.

KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation.

Kidder BL, Hu G, Zhao K.

Genome Biol. 2014 Feb 4;15(2):R32. doi: 10.1186/gb-2014-15-2-r32.

5.

Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.

Lizcano F, Garcia J.

Pharmaceuticals (Basel). 2012 Sep 12;5(9):963-90. doi: 10.3390/ph5090963.

6.
7.

Extended self-renewal and accelerated reprogramming in the absence of Kdm5b.

Kidder BL, Hu G, Yu ZX, Liu C, Zhao K.

Mol Cell Biol. 2013 Dec;33(24):4793-810. doi: 10.1128/MCB.00692-13. Epub 2013 Oct 7.

8.

Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells.

Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, Körbel C, Laschke MW, Gimotty PA, Philipp SE, Krause E, Pätzold S, Villanueva J, Krepler C, Fukunaga-Kalabis M, Hoth M, Bastian BC, Vogt T, Herlyn M.

Cancer Cell. 2013 Jun 10;23(6):811-25. doi: 10.1016/j.ccr.2013.05.003.

9.

The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.

Hasan UA, Zannetti C, Parroche P, Goutagny N, Malfroy M, Roblot G, Carreira C, Hussain I, Müller M, Taylor-Papadimitriou J, Picard D, Sylla BS, Trinchieri G, Medzhitov R, Tommasino M.

J Exp Med. 2013 Jul 1;210(7):1369-87. doi: 10.1084/jem.20122394. Epub 2013 Jun 10.

10.

The histone demethylase Jarid1b ensures faithful mouse development by protecting developmental genes from aberrant H3K4me3.

Albert M, Schmitz SU, Kooistra SM, Malatesta M, Morales Torres C, Rekling JC, Johansen JV, Abarrategui I, Helin K.

PLoS Genet. 2013 Apr;9(4):e1003461. doi: 10.1371/journal.pgen.1003461. Epub 2013 Apr 18.

11.

Timing of transcriptional quiescence during gametogenesis is controlled by global histone H3K4 demethylation.

Xu M, Soloveychik M, Ranger M, Schertzberg M, Shah Z, Raisner R, Venkatasubrahmanyan S, Tsui K, Gebbia M, Hughes T, van Bakel H, Nislow C, Madhani HD, Meneghini MD.

Dev Cell. 2012 Nov 13;23(5):1059-71. doi: 10.1016/j.devcel.2012.10.005. Epub 2012 Nov 1.

12.

Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.

Kaelin WG Jr.

Cold Spring Harb Symp Quant Biol. 2011;76:335-45. doi: 10.1101/sqb.2011.76.010975. Epub 2011 Nov 16. Review.

13.

Jarid1b targets genes regulating development and is involved in neural differentiation.

Schmitz SU, Albert M, Malatesta M, Morey L, Johansen JV, Bak M, Tommerup N, Abarrategui I, Helin K.

EMBO J. 2011 Nov 16;30(22):4586-600. doi: 10.1038/emboj.2011.383.

14.

Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation.

Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, Jonasova A, Necas E, Zavadil J, Laslo P, Stopka T.

EMBO J. 2011 Sep 6;30(21):4450-64. doi: 10.1038/emboj.2011.317.

15.

lincRNAs act in the circuitry controlling pluripotency and differentiation.

Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, Yang X, Amit I, Meissner A, Regev A, Rinn JL, Root DE, Lander ES.

Nature. 2011 Aug 28;477(7364):295-300. doi: 10.1038/nature10398.

16.

Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1.

Lin W, Cao J, Liu J, Beshiri ML, Fujiwara Y, Francis J, Cherniack AD, Geisen C, Blair LP, Zou MR, Shen X, Kawamori D, Liu Z, Grisanzio C, Watanabe H, Minamishima YA, Zhang Q, Kulkarni RN, Signoretti S, Rodig SJ, Bronson RT, Orkin SH, Tuck DP, Benevolenskaya EV, Meyerson M, Kaelin WG Jr, Yan Q.

Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13379-86. doi: 10.1073/pnas.1110104108. Epub 2011 Jul 25.

17.

In vivo and ex vivo MR imaging of slowly cycling melanoma cells.

Magnitsky S, Roesch A, Herlyn M, Glickson JD.

Magn Reson Med. 2011 Nov;66(5):1362-73. doi: 10.1002/mrm.22917. Epub 2011 Apr 26.

18.

Suppression of cryptic intragenic transcripts is required for embryonic stem cell self-renewal.

Lin CH, Workman JL.

EMBO J. 2011 Apr 20;30(8):1420-1. doi: 10.1038/emboj.2011.99. No abstract available.

19.

KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription.

Xie L, Pelz C, Wang W, Bashar A, Varlamova O, Shadle S, Impey S.

EMBO J. 2011 Apr 20;30(8):1473-84. doi: 10.1038/emboj.2011.91. Epub 2011 Mar 29.

20.

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M.

Cell. 2010 May 14;141(4):583-94. doi: 10.1016/j.cell.2010.04.020.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk